Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Tangible Net Worth Ratio
Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Tangible Net Worth Ratio of 72.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥104.55 Million) from net assets (CN¥377.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Zhuhai Sailong Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhuhai Sailong Pharmaceutical Co Ltd Tangible Net Worth Ratio (2013–2025)
This chart shows how Zhuhai Sailong Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 72.3%, reflecting net assets of CN¥377.94 Million with intangible assets of CN¥104.55 Million CNY. See 002898 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Zhuhai Sailong Pharmaceutical Co Ltd worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.6% | CN¥384.15 Million | CN¥105.07 Million | CN¥832.10 Million | ▼ -2.6 pp |
| 2024 | 75.2% | CN¥499.28 Million | CN¥123.81 Million | CN¥808.22 Million | ▼ -3.8 pp |
| 2023 | 79.0% | CN¥535.88 Million | CN¥112.73 Million | CN¥813.84 Million | ▼ -1.2 pp |
| 2022 | 80.2% | CN¥526.35 Million | CN¥104.46 Million | CN¥847.99 Million | ▼ -1.5 pp |
| 2021 | 81.6% | CN¥563.66 Million | CN¥103.68 Million | CN¥882.78 Million | ▼ -1.7 pp |
| 2020 | 83.3% | CN¥587.00 Million | CN¥98.15 Million | CN¥813.96 Million | ▼ -2.3 pp |
| 2019 | 85.6% | CN¥659.02 Million | CN¥94.93 Million | CN¥835.98 Million | ▼ -5.3 pp |
| 2018 | 90.9% | CN¥663.54 Million | CN¥60.52 Million | CN¥755.84 Million | ▼ -0.8 pp |
| 2017 | 91.7% | CN¥618.64 Million | CN¥51.43 Million | CN¥715.13 Million | ▲ +10.3 pp |
| 2016 | 81.3% | CN¥254.45 Million | CN¥47.48 Million | CN¥305.66 Million | ▲ +4.1 pp |
| 2015 | 77.2% | CN¥213.20 Million | CN¥48.51 Million | CN¥264.73 Million | ▲ +12.5 pp |
| 2014 | 64.7% | CN¥140.55 Million | CN¥49.57 Million | CN¥189.48 Million | ▼ -31.8 pp |
| 2013 | 96.5% | CN¥111.97 Million | CN¥3.86 Million | CN¥186.41 Million | — |